SLE drug safety registry for adults with lupus
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This registry tracks the safety and effectiveness of lupus treatments over time. If you have SLE and are starting a new treatment or were recently diagnosed, joining helps doctors learn which medicines work best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and diagnosed with SLE by a rheumatologist.
- You are willing to share your name, birth date, sex, and zip code for the registry.
- You must have been diagnosed with SLE within the past 12 months, OR be starting a biologic or immunosuppressant for SLE, OR have had lupus nephritis (kidney lupus) diagnosed in the last 2 years.
- You cannot be in a double-blind clinical trial for SLE at the same time.
- You cannot be in a trial for CAR-T or other cell/gene therapy for SLE unless the trial is not blinded.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study aims to better understand systemic lupus erythematosus (SLE), an autoimmune disease where the body's immune system attacks its own tissues. Researchers will evaluate patients with lupus, study genetic factors, and perform optional imaging tests to learn how the disease affects blood vessels and the heart.
This trial is a registry that follows people with lupus to help Duke researchers learn about the disease and care. You may be able to join if you’re seen by a Duke rheumatologist and can come to follow-up visits.
This study tests a new drug called LBL-047 in healthy people and in people with mild to moderate lupus. It helps check if the drug is safe and how the body processes it. Participating may help find better treatments for lupus.
This study looks back at medical records of people with SLE in Egypt to learn more about their health and treatments. It does not test any new drug or treatment.
This study creates a registry for people with systemic lupus erythematosus (SLE) to track the disease over time. Joining helps researchers learn more about lupus and may improve care for future patients.
This study keeps a long-term record of people with lupus (systemic lupus erythematosus) and collects samples so researchers can study the disease better. You may be able to join if you meet lupus diagnosis criteria, are not pregnant, and can follow the study visits and consent process.
Hear when a new Systemic Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.